{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:23:27Z","timestamp":1759332207792},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.imlet.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:18:31Z","timestamp":1297783111000},"page":"46-52","source":"Crossref","is-referenced-by-count":7,"title":["Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol\u2013peptide conjugates"],"prefix":"10.1016","volume":"137","author":[{"given":"Behzod Z.","family":"Dolimbek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Roger","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zouhair","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2011.02.002_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1615\/CritRevImmunol.v30.i2.50","article-title":"Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition","volume":"30","author":"Aoki","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0010","first-page":"219","article-title":"Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0015","series-title":"Scientific and therapeutic aspects of botulinum toxin","first-page":"409","article-title":"Botulinum toxin: clinical implications of antigenicity and immunoresistance","author":"Jankovic","year":"2002"},{"key":"10.1016\/j.imlet.2011.02.002_bib0020","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/mds.20024","article-title":"Treatment of cervical dystonia with botulinum toxin","volume":"19","author":"Jankovic","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.imlet.2011.02.002_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.65.6.924","article-title":"Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin","volume":"65","author":"Naumann","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.imlet.2011.02.002_bib0030","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.imlet.2011.02.002_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies\u2014therapeutic consequences","volume":"147","author":"G\u00f6schel","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"Development of resistance to botulinum toxin type A in patients with torticollis","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.imlet.2011.02.002_bib0045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-003-1129-6","article-title":"Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure","volume":"250","author":"Dressler","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.imlet.2011.02.002_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection: type B compared with type A","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.imlet.2011.02.002_bib0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000081463","article-title":"Antibody-induced failure of botulinum toxin type B therapy in de novo patients","volume":"52","author":"Dressler","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0065","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01886751","article-title":"Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species","volume":"15","author":"Atassi","year":"1996","journal-title":"J Protein Chem"},{"key":"10.1016\/j.imlet.2011.02.002_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:JOPC.0000016257.91979.06","article-title":"Mapping of the antibody-binding regions on the HN-domain (residues 449\u2013859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A","volume":"23","author":"Atassi","year":"2004","journal-title":"Protein J"},{"key":"10.1016\/j.imlet.2011.02.002_bib0075","first-page":"119","article-title":"Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449\u2013859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains","volume":"34","author":"Dolimbek","year":"2005","journal-title":"Immunol Invest"},{"key":"10.1016\/j.imlet.2011.02.002_bib0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1615\/CritRevImmunol.v27.i4.30","article-title":"Molecular bases of protective immune responses against botulinum neurotoxin A\u2014how antitoxin antibodies block its action","volume":"27","author":"Atassi","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10930-010-9255-3","article-title":"Inhibition of botulinum neurotoxin A toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions","volume":"29","author":"Atassi","year":"2010","journal-title":"Protein J"},{"key":"10.1016\/j.imlet.2011.02.002_bib0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molimm.2006.03.011","article-title":"Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT\/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT\/A","volume":"44","author":"Dolimbek","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.molimm.2007.08.007","article-title":"Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin","volume":"45","author":"Dolimbek","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2010.10.010","article-title":"Regions of recognition by blocking antibodies on the light chain of BoNT\/A. Antigenic structure of the entire toxin","author":"Dolimbek","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2011.02.002_bib0105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10930-004-7881-3","article-title":"Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain","volume":"23","author":"Maruta","year":"2004","journal-title":"Protein J"},{"key":"10.1016\/j.imlet.2011.02.002_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneumeth.2005.05.026","article-title":"Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies","volume":"151","author":"Maruta","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.imlet.2011.02.002_bib0115","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1073\/pnas.89.13.5852","article-title":"Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide","volume":"89","author":"Atassi","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.imlet.2011.02.002_bib0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01025714","article-title":"Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides","volume":"10","author":"Atassi","year":"1991","journal-title":"J Protein Chem"},{"key":"10.1016\/j.imlet.2011.02.002_bib0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal Biochem"},{"key":"10.1016\/j.imlet.2011.02.002_bib0130","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1021\/jo00299a011","article-title":"Preparation and application of the 5-(4-(9-fluorenylmethyloxycarbonyl)aminoethyl-3 5-dimethoxyphenoxy)-valeric acid (PAL) handle for the solid-phase synthesis of C-terminal peptide amides under mild conditions","volume":"55","author":"Albericio","year":"1990","journal-title":"J Org Chem"},{"key":"10.1016\/j.imlet.2011.02.002_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08916930008995987","article-title":"T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses","volume":"32","author":"Oshima","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2011.02.002_bib0140","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.4049\/jimmunol.157.7.3192","article-title":"B-cell activation in vitro by helper T cells specific to region alpha 146\u2013162 of Torpedo californica nicotinic acetylcholine receptor","volume":"157","author":"Rosenberg","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.02.002_bib0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/08820139709022703","article-title":"Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies","volume":"26","author":"Rosenberg","year":"1997","journal-title":"Immunol Invest"},{"key":"10.1016\/j.imlet.2011.02.002_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08820139809089450","article-title":"B-cell activation in vitro by helper T cells specific to a protein region that is recognized both by T cells and by antibodies","volume":"27","author":"Hamajima","year":"1998","journal-title":"Immunol Invest"},{"key":"10.1016\/j.imlet.2011.02.002_bib0155","series-title":"Scientific and therapeutic aspects of botulinum toxin,","first-page":"103","article-title":"Immunologic and other properties of therapeutic botulinum toxin serotypes","author":"Aoki","year":"2002"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:37:02Z","timestamp":1685947022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247811000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0165247811000423"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2011.02.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}